Securinine, a myeloid differentiation agent with therapeutic potential for AML.

As the defining feature of Acute Myeloid Leukemia (AML) is a maturation arrest, a highly desirable therapeutic strategy is to induce leukemic cell maturation. This therapeutic strategy has the potential of avoiding the significant side effects that occur with the traditional AML therapeutics. We ide...

詳細記述

書誌詳細

主要な著者:	Kalpana Gupta, Amitabha Chakrabarti, Sonia Rana, Ritu Ramdeo, Bryan L Roth, Munna L Agarwal, William Tse, Mukesh K Agarwal, David N Wald
フォーマット:	Artigo
言語:	Inglês
出版事項:	Public Library of Science (PLoS) 2011-01-01
シリーズ:	PLoS ONE
オンライン･アクセス:	http://europepmc.org/articles/PMC3123298?pdf=render
タグ:	タグ追加 タグなし, このレコードへの初めてのタグを付けませんか!